Corporate Banner
Satellite Banner
ADME Tox
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

AB SCIEX and Phytronix Improve High-Throughput Pharmaceutical Application

Published: Thursday, October 18, 2012
Last Updated: Thursday, October 18, 2012
Bookmark and Share
Integration of LDTD with DiscoveryQuant software streamlines high-throughput method development.

AB SCIEX and Phytronix Technologies have announced the integration of Phytronix’s LDTD (Laser Diode Thermal Desorption) ion source with AB SCIEX’s DiscoveryQuant™ Software, giving discovery pharmaceutical scientists a faster, more streamlined method development process than was previously available for early ADME workflows.

The new solution was launched this week at the AAPS 2012 conference. It includes automated method optimization and is ideally suited for laboratories that run thousands of samples per day in a regulated environment, especially those with the need for global connectivity to compound database libraries.

The integration gives scientists the ability to use DiscoveryQuant Software to control the LDTD source and, when coupled with the AB SCIEX Triple Quad™ and QTRAP® mass spectrometry portfolio, to achieve speeds that rival any other product for high-throughput applications in the market today, with sample-to-sample cycle times as low as four seconds.

This MS/MS solution bypasses LC time scales, providing a much faster approach to method development and optimization. It is expected to improve efficiency and boost productivity.

“We are delivering on the promise of our initial collaboration announcement with AB SCIEX one year ago,” said Jean Lacoursiere, President of Phytronix Technologies. “We are delivering a more comprehensive and truly unmatched tool for drug discovery. We are proving that LDTD-MS/MS is a winning combination.”

By combining the LDTD source with DiscoveryQuant software, it is possible to automatically determine optimal ion path parameters for maximum sensitivity, while populating a shared central database with this critical information.

DiscoveryQuant can then access this method database for use in assays with the LDTD source. The output of this new LDTD-MS/MS workflow feeds into compound database libraries that pharmaceutical scientists need to advance their drug discovery and development work, and allows researchers worldwide to share MS/MS methodologies online.

“Working with innovative front-end source providers such as Phytronix is part of AB SCIEX’s commitment to the high-throughput market,” said Dave Hicks, Vice President of the Pharmaceutical and Academic Business at AB SCIEX.

Hicks continued, “With our expertise in software for MS/MS applications, we have extended our partnership with Phytronix to give pharmaceutical scientists access to a novel workflow that pushes the limits.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

SCIEX and Hepregen Announce Co-Marketing Agreement
Alliance establishes SCIEX and Hepregen as a one-stop solution provider for drug metabolism investigators.
Friday, May 22, 2015
Sciex, Hepregen Team up on Metabolite Identification Offering
This recently announced collaboration aims to provide practical solutions for drug metabolism researchers.
Thursday, May 21, 2015
AB SCIEX Wins New Product Innovation Award in Asia Pacific
The award recognizes the company’s continued innovation in the mass spectrometry industry and a number of new products introduced into the market in recent years.
Thursday, October 30, 2014
AB SCIEX and Indigo to Market Mass Spectrometry Solutions
AB SCIEX and Indigo BioSystems have entered into a collaboration to jointly market mass spectrometry solutions that simplifies LC/MS/MS workflows.
Tuesday, January 17, 2012
Scientific News
Advancing Synthetic Biology
Living systems rely on a dizzying variety of chemical reactions essential to development and survival. Most of these involve a specialized class of protein molecules — the enzymes.
Insights into the Function of the Main Class of Drug Targets
About thirty percent of all medical drugs such as beta-blockers or antidepressants interact with certain types of cell surface proteins called G protein coupled receptors.
Honey’s Potential to Save Lives
The healing powers of honey have been known for thousands of years.
Muscles on-a-Chip
This study may help explain why stem cell-based therapies have so far shown limited benefits for heart attack patients in clinical trials.
3-D Printed Lifelike Liver Tissue for Drug Screening
A team led by engineers at the University of California, San Diego has 3D-printed a tissue that closely mimics the human liver's sophisticated structure and function. The new model could be used for patient-specific drug screening and disease modeling.
Envigo Rat Models Proven to be Susceptible to Intra-Vaginal HSV-2 Infection and Protectable
Scientific findings establish the effectiveness of new approach to investigate the protective effects of vaccine candidates and anti-viral microbodies and to study asymptomatic primary genital HSV-2 infection.
Valvena, GSK Sign New R&D Collaboration
Valneva to supply process development services for EB66® -based Influenza vaccines.
Food Triggers Creation of Regulatory T Cells
IBS researchers document how normal diet establishes immune tolerance conditions in the small intestine.
Counting Cancer-busting Oxygen Molecules
Researchers from the Centre for Nanoscale BioPhotonics (CNBP), an Australian Research Centre of Excellence, have shown that nanoparticles used in combination with X-rays, are a viable method for killing cancer cells deep within the living body.
Crowdfunding the Fight Against Cancer
From budding social causes to groundbreaking businesses to the next big band, crowdfunding has helped connect countless worthy projects with like-minded people willing to support their efforts, even in small ways. But could crowdfunding help fight cancer?
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!